The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Cardiac Marker Market Between 2026 And 2030?
The cardiac marker market size has seen swift expansion in recent times. It is anticipated to increase from $12.38 billion in 2025 to $13.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been fueled by the escalating prevalence of cardiovascular diseases, the enhancement of hospital laboratory infrastructure, the increased utilization of emergency cardiac testing, a rising reliance on biomarker-based diagnosis, and advancements in assay sensitivity.
The cardiac marker market is projected for substantial expansion over the coming years, with its size expected to reach $22.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.9%. This growth in the forecast period can be attributed to factors such as increasing demand for quicker diagnostic tests, the rising integration of cardiac diagnostics with digital platforms, the expansion of point-of-care testing facilities, a growing adoption of advanced biomarker panels, and an increasing focus on precision cardiology. Major trends anticipated during this period include the rising use of high-specificity cardiac marker panels, increased adoption of automated immunoassay systems, a growing need for rapid cardiac diagnosis, the expansion of multiparametric testing approaches, and an enhanced focus on clinical decision support.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp
What Primary Factors Are Fueling The Expansion Of The Cardiac Marker Market?
An increasing incidence of cardiac diseases is anticipated to drive the expansion of the cardiac marker market moving forward. Cardiac diseases involve various conditions that impact the heart’s structure or function, resulting in a spectrum of health complications. Cardiac markers are utilized for diagnosing and tracking numerous cardiac conditions, including heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for these diagnostic tests, or cardiac markers, has grown. For example, in January 2024, as reported by the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% rise from 224.4 per 100,000 in 2023. Thus, the escalating prevalence of cardiac diseases will bolster the cardiac marker market’s growth.
Which Segment-Based Categories Are Covered In The Cardiac Marker Market?
The cardiac marker market covered in this report is segmented –
1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers
2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA
3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications
4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions
Subsegments:
1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits
2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels
3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels
4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels
5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)
Which Trends Are Contributing To Changes In The Cardiac Marker Market?
Leading companies active in the cardiac marker market are concentrating on innovative product development, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to enhance their revenues. These two crucial cardiac biomarkers, high-sensitivity troponin I (hs-cTnI) and NT-proBNP, play a vital role in diagnosis, classification, and treatment. An illustration of this trend occurred in October 2023 when Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company specializing in medical equipment and solutions, launched its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay specifically exceeds the baseline criteria for hs-cTn in its ability to identify myocardial damage with high sensitivity, accuracy, and reliability. These recently introduced products are designed to support better management of cardiovascular illnesses by offering dependable solutions that lead to improved patient outcomes, both within and outside the scope of cardiovascular care.
Who Are The Leading Firms Participating In The Cardiac Marker Market?
Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics
Access The Complete Cardiac Marker Market Report:
https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report
What Is The Largest Regional Market In The Cardiac Marker Market?
North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Cardiac Marker Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp
Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company
Arrhythmia Monitoring Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report
Cardiac Arrhythmia Monitoring Devices Market Report 2026
Wearable Heart Monitoring Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model